Top Commitment
"Creating Social Value Through ESG as We Become a Total Healthcare Company"
President, Representative Director
Promoting ESG management is one of our key initiatives and an integral part of our corporate philosophy of “Contribute toward the improvement of people’s health and progress in society through the development of innovative products.” When we adopted the holdings structure in 2021, we also established the ESG Committee. Since then, the committee has been the impetus in identifying and analyzing material issues that should be taken up by the entire Group. In addition, the committee is striving to practice corporate philosophy, enhance corporate value over the medium to long term, and to construct relationships of trust with all our stakeholders.
We have set specific numerical targets related to the environment (the E in ESG). These include targets related to our measures to address climate change and to reduce CO2 emissions by expanding solar power equipment and introducing clean energy, as we work to realize eco-friendly business management.
In terms of society (S), we intend to continue the unique activities of each of our businesses based on their particular approach of contributing to society, such as contributing to people’s health and enhancing their quality of life. One of the Group’s major social missions is to support the healthy lives of women throughout each life stage by leveraging the information communication capabilities of Health Lab Mint+ for Women’s Health, which we established in 2020. In addition, in the animal health field, we will advance animal health and food safety as we work to create a society where people and animals can coexist in harmony.
In terms of governance (G), we upgraded the Groupwide governance structure to manage our businesses in line with a unified policy. Recently, we have been working to create workplaces where everyone can thrive, with a focus on hiring and training that emphasizes diversity, to enable the effective collaboration of human resources spanning a wide range of nationalities and cultural backgrounds.
The Group will not only seek to maximize economic value through our business, but also strive to enhance social value as we continue living up to the expectations of our shareholders. We appreciate the continued understanding and support of all our stakeholders.
Sohta Yamaguchi
President, Representative Director
(As of June 24, 2025)
Pursuing Sustainability in Tandem with Business Development
As articulated in the corporate philosophy of “Contribute
toward the improvement of people’s health and progress in
society through the development of innovative products,”
the Group seeks to resolve social issues and build a
sustainable society through its business. Our business
activities are profoundly linked to life and health. As such,
we believe that our commitment to the pharmaceutical
business (particularly in the field of obstetrics and
gynecology), as well as to the animal health business and
testing business, represents sustainability in practice and lies
at the heart of our ESG (environmental, social, and
governance) management.
From the perspective of sustainable corporate growth
and social contribution, we have identified six material issues
that we think are our most important management priorities.
These issues include “Contribution to women’s health and
animal health,” which we aim to achieve through our own
unique approach to value creation.
The Group is actively pursuing sustainability based on the
belief that it is not simply a responsibility, but also a key driver
of growth. Creating innovative new drugs that support
women’s health and establishing a system for the stable
supply of high-quality pharmaceuticals will serve not only as
social infrastructure that enables women to live healthy lives,
but also as a foundation for the Group’s sustainable business
growth. Essentially, we seek to create social value in the
healthcare field by leveraging a business structure in which
business and sustainability are closely intertwined.
Human resources are the bedrock of our sustainability
initiatives. We seek to build a virtuous cycle in which
continuous investment in human resources leads to the
creation of valuable products that in turn make a positive
contribution to healthcare and society. We view respect for
human rights as another essential component of ESG
management, and to that end we are stepping up efforts to
comply with international human rights principles.
As a company that is proactively addressing global
environmental issues while acting as a member of the local
community, we have a responsibility to protect the
environment and reduce our environmental footprint. In
working toward achieving a carbon-neutral society, we have
established an environmental management structure and
begun disclosing information in compliance with international
frameworks such as the Task Force on Climate-related
Financial Disclosures (TCFD), while continuing to reduce our
environmental footprint to achieve the goals unanimously
agreed upon by society.
We are also paying more attention to natural capital in
accordance with the Task Force on Nature-related Financial
Disclosures (TNFD) framework, and are committed to
preserving biodiversity and sustainably utilizing ecosystem
services. Looking ahead, we aim to continue contributing to
the realization of a better future through healthcare-focused
value creation initiatives unique to the Group.
Atsushi Maruo
In Charge of Sustainability
Senior Managing Member of the Board of Directors, Representative Director
(As of September 30, 2025)